| [1] |
Theodosiou A , Ashworth A . MAP kinase phosphatases. Genome Biology, 2002, 3:1-10.
|
| [2] |
Kidger, Andrew M, Keyse, Stephen M. The regulation of oncogenic Ras/ERK signalling by dual-specificity mitogen activated protein kinase phosphatases (MKPs). Seminars in Cell & Developmental Biology, 2016, 50: 125-32.
|
| [3] |
Tarrega C, Nunes-Xavier C, Cejudo-Marin R, et al. Studying the regulation of MAP Kinase by MAP Kinase phosphatases in vitro and in cell systems. Methods Mol Biol, 2010, 661: 305-21.
|
| [4] |
Owens DM, Keyse SM. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene, 2007, 26: 3203-13.
|
| [5] |
Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology, 2003, 37: 917-23.
|
| [6] |
Day CP, James OFW. Steatohepatitis: A tale of two 'Hits'?. Gastroenterology, 1998, 114:842-845.
|
| [7] |
Kodama Y , Brenner DA . c-Jun N-terminal kinase signaling in the pathogenesis of nonalcoholic fatty liver disease: multiple roles in multiple steps. Hepatology, 2009, 49:6-8.
|
| [8] |
Cao W, Collins QF, Becker TC , et al. p38 Mitogen-activated protein kinase plays a stimulatory role in hepatic gluconeogenesis. Journal of Biological Chemistry, 2005, 280:42731-42737.
|
| [9] |
Lawan A, Bennett AM. Mitogen-activated protein kinase regulation in hepatic metabolism. Trends in Endocrinology and Metabolism, 2017, 28:868-878.
|
| [10] |
Hunter RH. Sperm:egg ratios and putative molecular signals to modulate gamete interactions in polytocous mammals. Mol Reprod Dev, 1993, 35: 324-327.
|
| [11] |
Lawan A, Zhang L, Gatzke F, et al. Hepatic mitogen-activated protein kinase phosphatase 1 selectively regulates glucose metabolism and energy homeostasis. Mol Cell Biol, 2015, 35: 26-40.
|
| [12] |
Roth RJ, Le AM, Zhang L, et al. MAPK phosphatase-1 facilitates the loss of oxidative myofibers associated with obesity in mice. J Clin Invest, 2009, 119: 3817-3829.
|
| [13] |
Jenner S, Wiedorn KH, TECHEL D. Development of a DUSP9 methylation screening assay. Pathol Oncol Res, 2015, 21: 123-130.
|
| [14] |
Dickinson RJ, Williams DJ, Slack DN, et al. Characterization of a murine gene encoding a developmentally regulated cytoplasmic dual-specificity mitogen-activated protein kinase phosphatase. Biochem J, 2002, 364: 145-155.
|
| [15] |
Muda M, Boschert U, Smith A, et al. Molecular cloning and functional characterization of a novel mitogen-activated protein kinase phosphatase, MKP-4. J Biol Chem, 1997, 272: 5141-5151.
|
| [16] |
Dickinson RJ, Delavaine L, Cejudo-Marin R, et al. Phosphorylation of the kinase interaction motif in mitogen-activated protein (MAP) kinase phosphatase-4 mediates cross-talk between protein kinase A and MAP kinase signaling pathways. J Biol Chem, 2011, 286: 38018-38026.
|
| [17] |
Bao XY, Peng B, Yang M S. Replication study of novel risk variants in six genes with type 2 diabetes and related quantitative traits in the Han Chinese lean individuals. Mol Biol Rep, 2012, 39: 2447-54.
|
| [18] |
Voight BF, Scott LJ, Steinthorsdottir V, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet, 2010, 42: 579-589.
|
| [19] |
Fukuda H, Imamura M, Tanaka Y, et al. A single nucleotide polymorphism within DUSP9 is associated with susceptibility to type 2 diabetes in a Japanese population. PLoS One, 2012, 7: e46263.
|
| [20] |
Lakbakbi El Yaagoubi F, Charoute H, Morjane I, et al. Association analysis of genetic variants with metabolic syndrome components in the Moroccan population. Curr Res Transl Med, 2017, 65: 121-125.
|
| [21] |
Ye P, Xiang M, Liao H, et al. Dual-specificity phosphatase 9 protects against nonalcoholic fatty liver disease in mice through ASK1 suppression. Hepatology, 2019, 69: 76-93.
|
| [22] |
Muda M, Manning ER, Orth K, et al. Identification of the human YVH1 protein-tyrosine phosphatase orthologue reveals a novel zinc binding domain essential for in vivo function. J Biol Chem, 1999, 274: 23991-23995.
|
| [23] |
Munoz-Alonso MJ, Guillemain G, Kassis N, et al. A novel cytosolic dual specificity phosphatase, interacting with glucokinase, increases glucose phosphorylation rate. J Biol Chem, 2000, 275: 32406-32412.
|
| [24] |
Huang Z, Wu LM, Zhang JL, et al. Dual specificity phosphatase 12 regulates hepatic lipid metabolism through inhibition of the lipogenesis and apoptosis signal-regulating kinase 1 pathways. Hepatology, 2019, 70: 1099-1118.
|
| [25] |
Marti F, Krause A, Post NH, et al. Negative-feedback regulation of CD28 costimulation by a novel mitogen-activated protein kinase phosphatase, MKP6. J Immunol, 2001, 166: 197-206.
|
| [26] |
Klinger S, Poussin C, Debril MB, et al. Increasing GLP-1-induced beta-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-alpha and DUSP14. Diabetes, 2008, 57: 584-593.
|
| [27] |
Wang S, Yan ZZ, Yang X, et al. Hepatocyte DUSP14 maintains metabolic homeostasis and suppresses inflammation in the liver. Hepatology, 2018, 67: 1320-1338.
|
| [28] |
Wang JY, Lin CH, Yang CH, et al. Biochemical and biological characterization of a neuroendocrine-associated phosphatase. J Neurochem, 2006, 98: 89-101.
|
| [29] |
Wang JY, Yang CH, Yeh CL, et al. NEAP causes down-regulation of EGFR, subsequently induces the suppression of NGF-induced differentiation in PC12 cells. J Neurochem, 2008, 107: 1544-1555.
|
| [30] |
Ye P, Liu J, Xu W, et al. Dual-specificity phosphatase 26 protects against nonalcoholic fatty liver disease in mice through transforming growth factor beta-activated kinase 1 suppression. Hepatology, 2019, 69: 1946-1964.
|
